The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial
Open Access
- 1 November 2024
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 8 (21) , 5683-5694
Abstract
Oral iron is first-line medication for iron deficiency anemia in pregnancy. We conducted a pilot randomized trial to investigate the impact of different doses of oral iron supplementation started early in pregnancy on women without anemia for 4 main outcomes: recruitment and protocol compliance, adherence, maintenance of maternal hemoglobin, and side effects. At antenatal clinic visits, participants were allocated to 1 of 3 trial arms in a 1:1:1 ratio: 200 mg ferrous sulfate daily, alternate days, or 3 times per week. The participants were followed to delivery. Baseline characteristics of 300 recruited participants were well matched between trial arms. The mean proportion of tablets taken as expected per participant was 82.5% overall (72.3%, 89.6%, and 84.5% for the daily, alternate days, and 3 times a week arm, respectively). There was a lower overall adherence rate in the daily arm (47%) than in the alternate days (62%) and the 3 times per week (61%) arms. A reduction in hemoglobin between randomization and 28 weeks’ gestation seemed smaller for the daily arm. A range of side effects were commonly reported at baseline before starting interventions and at later antenatal visits. Many side effects of iron overlapped with normal pregnancy symptoms. A daily iron dosing schedule might give the best opportunity for delivering an adequate iron load during pregnancy in women without anemia. Further randomized trials powered on clinical outcomes are needed to establish the clinical effectiveness of oral iron supplementation to prevent iron deficiency anemia. This study was registered (#ISRCTN12911644).Keywords
This publication has 35 references indexed in Scilit:
- Alternate day versus consecutive day oral iron supplementation in iron-depleted women: a randomized double-blind placebo-controlled studyeClinicalMedicine, 2023
- Anaemia in pregnancy: a major global health problemThe Lancet, 2023
- Severity of Anemia During Pregnancy and Adverse Maternal and Fetal OutcomesJAMA Network Open, 2022
- Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018Nature Medicine, 2021
- Iron deficiency in pregnancyAmerican Journal of Obstetrics and Gynecology, 2020
- Association of Prenatal Maternal Anemia With Neurodevelopmental DisordersJAMA Psychiatry, 2019
- Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysisThe Lancet Global Health, 2018
- Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trialsThe Lancet Haematology, 2017
- Anemia and pregnancy outcomes: a longitudinal studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2017
- Impact of Fetal-Neonatal Iron Deficiency on Recognition Memory at 2 Months of AgeThe Journal of Pediatrics, 2015